3/3/2026, 6:03:44 AM
Irvine, CA — March 3, 2026 — Leads & Copy — Bio Essence Corp. (OTCQB:BIOE), a U.S.-based biotechnology company focused on wellness and vitality through holistic products and AI-enabled platforms, announced it has been approved to upgrade to the OTCQB® Venture Market by OTC Markets Group Inc.
The company’s common stock is expected to begin trading on the OTCQB on February 26, 2026, under the ticker symbol BIOE. The OTCQB Venture Market is designed for entrepreneurial and development-stage companies in the United States and abroad. The company has served healthcare practitioners for more than 24 years.
Ms. Yin Yan, JD, MBA, Chief Executive Officer of Bio Essence Corp., said the OTCQB upgrade reflects the company’s commitment to transparency, regulatory compliance, and expanded investor access. She said eligibility for the OTCQB requires companies to be current in their reporting, complete annual verification and management certification, meet minimum bid price standards, and maintain strong corporate governance practices.
Ms. Yan added that the OTCQB is a leading marketplace for early-stage and growth-oriented U.S. and international companies that are committed to timely disclosure and high standards of financial reporting. She believes the upgrade represents a step forward as the company strengthens its credibility in the public markets and advances its long-term growth strategy.
The company believes that trading on the OTCQB will provide increased market visibility, access to real-time Level 2 quotations, and broader exposure to the investment community, while continuing to meet all ongoing OTCQB compliance and disclosure requirements.
The company’s mission is to promote wellness and vitality through a lifestyle supported by holistic products and practices. Bio Essence is pursuing growth strategies that include the development of AI-enabled platforms to support its expanding product and service offerings.
Any offering is being made solely by means of the Company’s offering circular and related offering documents. Prospective investors should review these documents carefully before making an investment decision. Copies of the offering materials are available on the Company’s designated offering page.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall it constitute an offer, solicitation, or sale in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under applicable securities laws.
This press release contains forward-looking statements within the meaning of applicable securities laws. These statements include, but are not limited to, statements regarding the OTCQB upgrade, platform initiatives, growth strategies, and future operations. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, including regulatory requirements, market conditions, execution risks, and other factors described in the Company’s offering documents and public filings.
Source: Bio Essence Corp.
